245 related articles for article (PubMed ID: 29332564)
21. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.
Ophelders DR; Wolfs TG; Jellema RK; Zwanenburg A; Andriessen P; Delhaas T; Ludwig AK; Radtke S; Peters V; Janssen L; Giebel B; Kramer BW
Stem Cells Transl Med; 2016 Jun; 5(6):754-63. PubMed ID: 27160705
[TBL] [Abstract][Full Text] [Related]
22. Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.
Gao L; Xu W; Li T; Chen J; Shao A; Yan F; Chen G
Cell Transplant; 2018 Dec; 27(12):1809-1824. PubMed ID: 29871521
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of stem cell-based therapies for stroke.
Chrostek MR; Fellows EG; Crane AT; Grande AW; Low WC
Brain Res; 2019 Nov; 1722():146362. PubMed ID: 31381876
[TBL] [Abstract][Full Text] [Related]
24. Lipoaspirate-derived adult mesenchymal stem cells improve functional outcome during intracerebral hemorrhage by proliferation of endogenous progenitor cells stem cells in intracerebral hemorrhages.
Fatar M; Stroick M; Griebe M; Marwedel I; Kern S; Bieback K; Giesel FL; Zechmann C; Kreisel S; Vollmar F; Alonso A; Back W; Meairs S; Hennerici MG
Neurosci Lett; 2008 Oct; 443(3):174-8. PubMed ID: 18691631
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
[TBL] [Abstract][Full Text] [Related]
26. Role of Exosomes as a Treatment and Potential Biomarker for Stroke.
Otero-Ortega L; Laso-García F; Gómez-de Frutos M; Fuentes B; Diekhorst L; Díez-Tejedor E; Gutiérrez-Fernández M
Transl Stroke Res; 2019 Jun; 10(3):241-249. PubMed ID: 30105420
[TBL] [Abstract][Full Text] [Related]
27. A critical appraisal of experimental intracerebral hemorrhage research.
MacLellan CL; Paquette R; Colbourne F
J Cereb Blood Flow Metab; 2012 Apr; 32(4):612-27. PubMed ID: 22293989
[TBL] [Abstract][Full Text] [Related]
28. Cell replacement therapy for intracerebral hemorrhage.
Andres RH; Guzman R; Ducray AD; Mordasini P; Gera A; Barth A; Widmer HR; Steinberg GK
Neurosurg Focus; 2008; 24(3-4):E16. PubMed ID: 18341392
[TBL] [Abstract][Full Text] [Related]
29. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model.
Lee HJ; Kim KS; Park IH; Kim SU
PLoS One; 2007 Jan; 2(1):e156. PubMed ID: 17225860
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells: therapeutic outlook for stroke.
Honmou O; Onodera R; Sasaki M; Waxman SG; Kocsis JD
Trends Mol Med; 2012 May; 18(5):292-7. PubMed ID: 22459358
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem Cell Application and Its Therapeutic Mechanisms in Intracerebral Hemorrhage.
Yang G; Fan X; Mazhar M; Yang S; Xu H; Dechsupa N; Wang L
Front Cell Neurosci; 2022; 16():898497. PubMed ID: 35769327
[TBL] [Abstract][Full Text] [Related]
32. Buyang Huanwu Decoction (BYHWD) Enhances Angiogenic Effect of Mesenchymal Stem Cell by Upregulating VEGF Expression After Focal Cerebral Ischemia.
Yang J; Gao F; Zhang Y; Liu Y; Zhang D
J Mol Neurosci; 2015 Aug; 56(4):898-906. PubMed ID: 25796380
[TBL] [Abstract][Full Text] [Related]
33. [Perspectives of cell therapy in sequelae from cerebrovascular accidents].
Otero L; Zurita M; Bonilla C; Aguayo C; Rico MA; Vaquero J
Neurocirugia (Astur); 2012 Sep; 23(5):193-9. PubMed ID: 22858052
[TBL] [Abstract][Full Text] [Related]
34. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
[TBL] [Abstract][Full Text] [Related]
35. Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.
Rosca AM; Rayia DM; Tutuianu R
Curr Stem Cell Res Ther; 2017; 12(2):134-138. PubMed ID: 26496883
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
37. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.
Figueroa FE; Cuenca Moreno J; La Cava A
Expert Opin Drug Discov; 2014 May; 9(5):555-66. PubMed ID: 24655067
[TBL] [Abstract][Full Text] [Related]
38. Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat.
Quittet MS; Touzani O; Sindji L; Cayon J; Fillesoye F; Toutain J; Divoux D; Marteau L; Lecocq M; Roussel S; Montero-Menei CN; Bernaudin M
Acta Biomater; 2015 Mar; 15():77-88. PubMed ID: 25556361
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal Stem Cells for Ischemic Stroke: Progress and Possibilities.
Maria Ferri AL; Bersano A; Lisini D; Boncoraglio G; Frigerio S; Parati E
Curr Med Chem; 2016 May; 23(16):1598-608. PubMed ID: 26898654
[TBL] [Abstract][Full Text] [Related]
40. Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model.
Choi YK; Urnukhsaikhan E; Yoon HH; Seo YK; Park JK
Biotechnol J; 2016 Nov; 11(11):1397-1404. PubMed ID: 27440447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
